Outset Medical, Inc. (OM) | Rumor.io

Outset Medical

Attention (50-day avg)0%

Attention rank (50-day avg)#4,612

Bullish sentiment (50-day avg)85%

Price to earnings ratio-0.55

Market capitalization55.6M

Earnings per share-3.8

Dividend yield (TTM)—

Revenue (annual)119.5M

Net income (annual)-81.7M

Social

What share of all stock conversation is about OM?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% 0	0% -0.01

Feb 12

Outset Medical, Inc. (OM) is trading at a deeply undervalued price, with a market cap of $67 million and $169 million in cash, and low cash burn of around $40 million annually.
Institutional buying is increasing, with notable investors such as Bank of America, Blackrock, Nuveen, and Deutsche Bank acquiring significant stakes in the company, suggesting a potential short squeeze or buyout.
Analysts are maintaining buy ratings with price targets of $12 and $15, despite the company's recent 70% decline in share price, with some investors betting on a potential turnaround or buyout.

Generated by AI

Sentiment

Of the messages about OM that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100%	100%	100% 0	75.03% +0.98
Bearish	0%	0%	0% 0	24.97% -0.98

Bullish· Jan 12

$OM has shown significant price increases, with shares surging +41% in pre-market trading and other posts indicating a potential rally from a base.
Outset Medical has reported positive financial results, including 5% revenue growth and $173M year-end cash balances, which may indicate a strong fundamental position for the company.
The stock has seen increased trading volume, with some posts indicating that shorts are becoming less active and that the company is preparing for a potential price increase, potentially due to upcoming events such as the JPM conference and earnings release.

Bearish· Apr 15

The company's CEO may have received private funding at steep discounts, potentially exacerbating the asset's price drop.
Insider moves or private sales of the asset may have contributed to the market's perception of the company's value.
The asset's price may be vulnerable to further declines due to a potential supply shock or the liquidation of short positions.

Generated by AI

Topics

Of the messages about OM that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Earnings	—	—	—	4.71%
Technical Analysis	—	—	—	45.79%
Analysts	—	—	—	21.89%
Announcements	—	—	—	18.18%
Controversies	—	—	—	0%
Macro	—	—	—	9.43%

Announcements· Mar 20

Outset Medical, Inc. (OM) is not mentioned in the provided post, which focuses on Inkw, Wint, and Walmart.
No relevant information about Outset Medical, Inc. (OM) was found in the provided post.
There is no market-relevant information about Outset Medical, Inc. (OM) to report.

Controversies· Jul 27

Investors have the opportunity to lead a securities fraud class action lawsuit against Outset Medical, Inc. (OM) for substantial losses sustained between September 15, 2020, and June 13, 2022.
The lawsuit alleges that Outset Medical, Inc. made false statements during this period, causing investors to suffer losses.
Investors who wish to serve as lead plaintiff in the lawsuit must submit their contact information by September 6, 2022, or contact Charles H. Linehan of GPM.

Generated by AI

Community

Of the messages about OM, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	100%	100%	29.76%
Newcomers	0%	0%	0%	70.24%

Regulars· Mar 20

The regulars are discussing the potential for Outset Medical, Inc. to expand its distribution within Walmart's bottled water sales, which are estimated to be $10 billion annually.
There is a mention of Greene Concepts, Inc. ($INKW) gearing up for expanded distribution within Walmart, which could impact Outset Medical's business.
The regulars are speculating about the sales figures of Outset Medical, with one post mentioning a strong sales performance.

Newcomers· Jan 12

The newcomer is excited about Outset Medical's potential turnaround, citing the company's cash runway and relatively low valuation.
The stock's surge in pre-market trading (+41%) is attributed to the company's unaudited fourth-quarter and 2025 results, which are being well-received by the market.
The newcomer reflects on a recent trade, highlighting the importance of following a process, avoiding selling too early, and improving level 2 market analysis to make more informed decisions.

Generated by AI

News

Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain Stock

Outset Medical (OM) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

1mo agoYahoo Finance

Wall Street Analysts Are Bullish on Top Healthcare Picks

Detailed price information for Outset Medical Inc (OM-Q) from The Globe and Mail including charting and trades.

1mo agotheglobeandmail.com

Outset Medical Q2 Earnings Call Highlights

1mo agoYahoo Finance

Also Discussed

Investors talking about OM also mention

#	Name	Attention
1	MANTRAMANTRA	0.02%0
2	Invesco Dorsey Wright Emerging Markets Momentum ETFPIE	0%new
3	ACCD - Accolade, Inc.	——
4	ENTR - ERShares Entrepreneur ETF	——
5	Atlas Trinity Tech Ltd.RAY	0%new
6	Bandwidth IncBAND	0%0
7	Camp4 Therapeutics CorporationCAMP	0%0
8	Alt5 Sigma CorpALTS	0%new
9	Western Copper and Gold CorporationWRN	0%0
10	TransUnionTRU	0.06%new

Outset Medical, Inc.

Healthcare
Medical Devices

Outset Medical, Inc. is a medical technology company focused on dialysis care. Its core product, the Tablo Hemodialysis System, is designed to simplify hemodialysis by combining integrated water purification, on-demand dialysate production, software, and connectivity in a compact platform. The company also provides related consumables and a data ecosystem that includes tools for healthcare providers, patients, and internal analytics. Outset Medical serves hospitals, dialysis clinics, and home-care settings, supporting dialysis delivery across the continuum of care. The company’s products are positioned to help healthcare providers manage dialysis programs with a more streamlined and technology-enabled workflow. Headquartered in San Jose, California, Outset Medical operates in the renal care and medical equipment markets, where it offers a specialized solution for patients and providers involved in kidney replacement therapy.

Website

Location

3052 Orchard Drive

San Jose, CA, 95134

United States

Social

What share of all stock conversation is about OM?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% 0	0% -0.01

Feb 12

Outset Medical, Inc. (OM) is trading at a deeply undervalued price, with a market cap of $67 million and $169 million in cash, and low cash burn of around $40 million annually.
Institutional buying is increasing, with notable investors such as Bank of America, Blackrock, Nuveen, and Deutsche Bank acquiring significant stakes in the company, suggesting a potential short squeeze or buyout.
Analysts are maintaining buy ratings with price targets of $12 and $15, despite the company's recent 70% decline in share price, with some investors betting on a potential turnaround or buyout.

Generated by AI

Sentiment

Of the messages about OM that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100%	100%	100% 0	75.03% +0.98
Bearish	0%	0%	0% 0	24.97% -0.98

Bullish· Jan 12

$OM has shown significant price increases, with shares surging +41% in pre-market trading and other posts indicating a potential rally from a base.
Outset Medical has reported positive financial results, including 5% revenue growth and $173M year-end cash balances, which may indicate a strong fundamental position for the company.
The stock has seen increased trading volume, with some posts indicating that shorts are becoming less active and that the company is preparing for a potential price increase, potentially due to upcoming events such as the JPM conference and earnings release.

Bearish· Apr 15

The company's CEO may have received private funding at steep discounts, potentially exacerbating the asset's price drop.
Insider moves or private sales of the asset may have contributed to the market's perception of the company's value.
The asset's price may be vulnerable to further declines due to a potential supply shock or the liquidation of short positions.

Generated by AI

Topics

Of the messages about OM that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Earnings	—	—	—	4.71%
Technical Analysis	—	—	—	45.79%
Analysts	—	—	—	21.89%
Announcements	—	—	—	18.18%
Controversies	—	—	—	0%
Macro	—	—	—	9.43%

Announcements· Mar 20

Outset Medical, Inc. (OM) is not mentioned in the provided post, which focuses on Inkw, Wint, and Walmart.
No relevant information about Outset Medical, Inc. (OM) was found in the provided post.
There is no market-relevant information about Outset Medical, Inc. (OM) to report.

Controversies· Jul 27

Investors have the opportunity to lead a securities fraud class action lawsuit against Outset Medical, Inc. (OM) for substantial losses sustained between September 15, 2020, and June 13, 2022.
The lawsuit alleges that Outset Medical, Inc. made false statements during this period, causing investors to suffer losses.
Investors who wish to serve as lead plaintiff in the lawsuit must submit their contact information by September 6, 2022, or contact Charles H. Linehan of GPM.

Generated by AI

Community

Of the messages about OM, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	100%	100%	29.76%
Newcomers	0%	0%	0%	70.24%

Regulars· Mar 20

The regulars are discussing the potential for Outset Medical, Inc. to expand its distribution within Walmart's bottled water sales, which are estimated to be $10 billion annually.
There is a mention of Greene Concepts, Inc. ($INKW) gearing up for expanded distribution within Walmart, which could impact Outset Medical's business.
The regulars are speculating about the sales figures of Outset Medical, with one post mentioning a strong sales performance.

Newcomers· Jan 12

The newcomer is excited about Outset Medical's potential turnaround, citing the company's cash runway and relatively low valuation.
The stock's surge in pre-market trading (+41%) is attributed to the company's unaudited fourth-quarter and 2025 results, which are being well-received by the market.
The newcomer reflects on a recent trade, highlighting the importance of following a process, avoiding selling too early, and improving level 2 market analysis to make more informed decisions.

Generated by AI

Outset Medical

Social

Feb 12

Bullish· Jan 12

Bearish· Apr 15

Announcements· Mar 20

Controversies· Jul 27

Regulars· Mar 20

Newcomers· Jan 12

Outset Medical CEO Leslie Trigg sells $15,088 in shares

Outset Medical general counsel sells $11,554 in stock

Outset Medical CFO Renee Gaeta sells $19,943 in stock

Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain Stock

Wall Street Analysts Are Bullish on Top Healthcare Picks

Outset Medical Q2 Earnings Call Highlights

Also Discussed

Outset Medical, Inc.

Company Information

Location

Outset Medical CEO Leslie Trigg sells $15,088 in shares

Outset Medical general counsel sells $11,554 in stock

Outset Medical CFO Renee Gaeta sells $19,943 in stock

Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain Stock

Wall Street Analysts Are Bullish on Top Healthcare Picks

Outset Medical Q2 Earnings Call Highlights

Also Discussed

Social

Feb 12

Bullish· Jan 12

Bearish· Apr 15

Announcements· Mar 20

Controversies· Jul 27

Regulars· Mar 20

Newcomers· Jan 12